Covered recipient · General Payments record
GAYATRI D NIMMAGADDA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$21,952.67
- Reported across 330 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000.00 | 1 |
| Travel and Lodging | $1,715.25 | 2 |
| Food and Beverage | $1,423.86 | 46 |
| Education | $206.67 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AVYXA PHARMA, LLC | $3,938.05 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $163.23 | 6 |
| Janssen Biotech, Inc. | $155.15 | 5 |
| Lilly USA, LLC | $147.15 | 3 |
| AVEO Pharmaceuticals, Inc. | $117.45 | 2 |
| Caris MPI, Inc. | $114.65 | 1 |
| GlaxoSmithKline, LLC. | $63.57 | 2 |
| GENZYME CORPORATION | $54.66 | 2 |
| ABBVIE INC. | $51.81 | 2 |
| Genentech USA, Inc. | $44.67 | 2 |
| PFIZER INC. | $43.13 | 2 |
| Gilead Sciences, Inc. | $37.79 | 2 |
| Acerta Pharma LLC | $33.88 | 1 |
| PharmaEssentia USA Corporation | $32.87 | 1 |
| Regeneron Healthcare Solutions, Inc. | $31.15 | 1 |
| Celgene Corporation | $29.41 | 1 |
| EISAI INC. | $28.91 | 1 |
| Geron Corporation | $28.56 | 1 |
| Fresenius Kabi USA, LLC | $25.44 | 1 |
| Iovance Biotherapeutics, Inc. | $24.74 | 1 |
| Azurity Pharmaceuticals, Inc. | $24.69 | 1 |
| Rigel Pharmaceuticals, Inc. | $24.43 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.38 | 1 |
| BeOne Medicines USA, Inc. | $20.05 | 1 |
| SOBI, INC | $19.68 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.63 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.96 | 1 |
| Sumitomo Pharma America, Inc. | $17.14 | 1 |
| Daiichi Sankyo Inc. | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.